Meera Joshi
appointed Ms. Meera Joshi as an independent director of the Company.
Highest-materiality recent filing
$120M revolving credit facility from DZ Bank, maturing Dec 30, 2030, secured by medallion loans under NYC MRP+ program.
Marblegate Capital dismisses Marcum as auditor, appoints Deloitte & Touche
Marcum LLP dismissed as auditor effective July 17, 2025; no disagreements, only a 2023 material weakness remedied in 2024.
Marblegate appoints Michael Hutchby as CFO; Jeffrey Kravetz resigns effective July 3, 2025
Jeffrey Kravetz resigns as CFO effective July 3, 2025; no disagreement with company, to focus on Marblegate Asset Management.
Business combination closed April 7, 2025; New MAC trading on OTCQX as MGTE and MGTEW.
Marblegate Capital appoints Meera Joshi as independent director
Appointment effective April 17, 2025; Joshi will serve on audit, compensation, and nominating committees.
Marblegate closes business combination with DePalma; stock to trade on OTCQX under MGTE
Closed combination with DePalma; DePalma valued at ~$629.5M; New MAC owns 83.7%.
Business combination closed April 7, 2025; common stock and warrants began trading on OTCQX under MGTE and MGTEW on April 10.
appointed Ms. Meera Joshi as an independent director of the Company.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
the executive officers of the Company are: • Andrew Milgram, Chief Executive Officer; • Paul Arrouet, President; and • Jeffrey Kravetz, Chief Financial Officer.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
the executive officers of the Company are: • Andrew Milgram, Chief Executive Officer; • Paul Arrouet, President; and • Jeffrey Kravetz, Chief Financial Officer.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
the executive officers of the Company are: • Andrew Milgram, Chief Executive Officer; • Paul Arrouet, President; and • Jeffrey Kravetz, Chief Financial Officer.
Max materiality 0.85 · Median 0.65 · Most common event other_material